Milestone Pharmaceuticals Inc.
MIST
$1.07
-$0.06-4.89%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -51.29% | -31.65% | -51.88% | -35.65% | -14.71% |
| Total Depreciation and Amortization | 16.38% | 12.25% | 7.59% | 5.89% | 6.07% |
| Total Amortization of Deferred Charges | 14.75% | 16.10% | 16.76% | 15.97% | 16.96% |
| Total Other Non-Cash Items | 115.24% | 69.69% | 27.59% | -5.00% | -19.63% |
| Change in Net Operating Assets | -29.38% | -71.00% | -26.59% | 270.79% | 958.30% |
| Cash from Operations | -51.79% | -51.01% | -70.00% | -35.56% | -9.30% |
| Capital Expenditure | -727.91% | -774.36% | -815.15% | 2.38% | 23.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -99.95% | -248.04% | 38.86% | 946.79% | 573.39% |
| Cash from Investing | -100.46% | -248.62% | 35.77% | 961.98% | 571.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 40,515.69% | 42,832.35% | 198.90% | 67.85% | -99.02% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 5,574.47% | -44.27% | -44.27% | -100.00% |
| Cash from Financing | 68,818.98% | 299,668.33% | 166.28% | 53.03% | -99.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 335.16% | -24.95% | 313.12% | 1,060.48% | 251.26% |